NewslettersPulmonary Cell NewsZai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival EndpointBy Jamie Kang - January 10, 20230274Zai Lab Limited and Novocure announced the LUNAR study met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in overall survival over standard therapies alone.[Zai Lab Limited]Press Release